La Trobe University researchers have identified the formula that works best in early detection of breast cancer. [ + ]

Two Australian Synchrotron users are among the 12 winners of the prestigious Victoria Fellowships for 2012. [ + ]

A new type of stem cell could be developed into therapies for cardiovascular disease and other indications, and is being pursued by Australian biotech start-up Cynata. [ + ]

Biotech companies are exploring alternative options to supplement their in-house research and development, abandoning the traditional blockbuster drug model to instead pursue deals and buy their way to success, says new report. [ + ]

Researchers at KU Leuven, Ghent University and the University of Antwerp have discovered a way to make new zeolites quickly. They have experimentally demonstrated that it is possible to cut zeolite building blocks and rearrange them into a new structure. [ + ]

The Balnaves Foundation’s Young Researcher of the Year Awards have reached their fifth year, enabling young researchers to pursue innovative ideas in the quest for a cure for childhood cancer. [ + ]

Young scientist Miriam-Rose Ash has been awarded the Australian Synchrotron Thesis Medal for her study into the essential roles that iron and copper play in living organisms. [ + ]

People working in scientific research are invited to participate in a survey examining careers in the biological sciences and chemistry related research workforce. [ + ]

Bioniche (ASX:BNC) has selected an exclusive US distributor for canine cancer product Immunocidin, which launched in the market last month. [ + ]

Professor Terry Speed says the government funding bodies and research institutions need to do more to offer a clear and stable career path for new bioinformaticians. [ + ]

Alchemia (ASX:ACL) will receive $1.5m for the September quarter – its first proper share of the profits from sales of anticoagulant generic fondaparinux. [ + ]

Personalised medicine, translational research, a blood donor register and insectary for researching malaria are all part of an upgraded WEHI facility opened today. [ + ]

The Australian health and medical research community gathered to recognised its best and brightest at the Research Australia Awards for 2012. [ + ]

The new redeveloped Walter and Eliza Hall Institute (WEHI) of Medical Research was officially opened today. The WEHI research facility, in Parkville, Victoria, will accommodate the institute’s rapidly expanding research programs in cancer, infectious disease and chronic inflammatory disease. [ + ]

A consortium of researchers is to embark on a £3 million research program which will use a common class of flower to restore poisoned soils while at the same time producing perfectly sized and shaped nanosized platinum and arsenic nanoparticles for use in catalytic convertors, cancer treatments and a range of other applications. [ + ]